HIGH-THROUGHPUT GENOMICS AND BIOINFORMATIC ANALYSIS SHARED RESOURCE ABSTRACT The High-Throughput Genomics and Bioinformatic Analysis Shared Resource (GBA) is dedicated to supporting the genomic experimentation and bioinformatic analysis needs of Huntsman Cancer Institute (HCI). Established in 1997, GBA consists of two closely-aligned sections, the Genomics Section, led by Brian Dalley, PhD, and the Bioinformatic Analysis Section, led by David Nix, PhD. Both Sections provide teams of genomic professionals who guide Cancer Center members through the experimental and analytical processes, support diverse protocols enabling state-of-the-art research, and continuously review and incorporate novel technologies for the benefit of HCI?s Research Programs. GBA?s aims are: 1) to provide state-of-the-art genomic technologies, services, and expertise, and 2) to support the scientific research objectives of the Cancer Center by enabling access to cost-effective, sophisticated genomic approaches for high-impact research, including team science grants. Management of GBA within the Cancer Center ensures that the Resource is focused on addressing the genomic technology needs of Cancer Center members. Specifically, GBA performs three essential functions: 1) recruit and train highly experienced scientists, bioinformaticians, and genomic technicians to support Cancer Center members, 2) provide a diverse portfolio of experimental protocols and analysis workflows to enable the latest research in genomics, and 3) evaluate, implement, and optimize genomic sequencing and bioanalytic infrastructure for the benefit of researchers at HCI. Cancer Center members with peer-reviewed funding comprise 28% of GBA users. Users benefit from the exceptional quality of the Resource at a highly subsidized cost, enabled through Cancer Center Support Grant and HCI support. Since 2014, over 80 publications have included experiments supported by the Resource. In summary, GBA provides a full-service facility to Cancer Center members and University of Utah investigators for state-of-the-art genomics research that spans the spectrum from experimental design, data generation, and in-depth integrated analysis to publication-quality figures and tables. The GS offers evaluation of sample quality, construction and qualification of Illumina sequencing libraries, and Illumina sequencing. The BAS conducts data analysis services that include processing raw data to primary results using well-developed analytic protocols for all of the major classes of next-generation sequencing applications. GBA also plays a key role in HCI?s translational genomics groups, which bring together investigators and clinicians who work with aggregated patient-derived datasets to improve clinical care. These comprehensive services enable investigators from diverse disciplines to use these powerful tools to inform their research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA042014-31
Application #
9935881
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-04-01
Budget End
2021-03-31
Support Year
31
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Utah
Department
Type
DUNS #
009095365
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Piñas, Germán E; DeSantis, Michael D; Parkinson, John S (2018) Noncritical Signaling Role of a Kinase-Receptor Interaction Surface in the Escherichia coli Chemosensory Core Complex. J Mol Biol 430:1051-1064
Sadler, Jessica B A; Wenzel, Dawn M; Williams, Lauren K et al. (2018) A cancer-associated polymorphism in ESCRT-III disrupts the abscission checkpoint and promotes genome instability. Proc Natl Acad Sci U S A 115:E8900-E8908
Stump, Tammy K; Aspinwall, Lisa G; Kohlmann, Wendy et al. (2018) Genetic Test Reporting and Counseling for Melanoma Risk in Minors May Improve Sun Protection Without Inducing Distress. J Genet Couns 27:955-967
Rambau, Peter F; Vierkant, Robert A; Intermaggio, Maria P et al. (2018) Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study. J Pathol Clin Res 4:250-261
Tavtigian, Sean V; Greenblatt, Marc S; Harrison, Steven M et al. (2018) Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification framework. Genet Med 20:1054-1060
Rogers, R Aaron; Fleming, Aaron M; Burrows, Cynthia J (2018) Unusual Isothermal Hysteresis in DNA i-Motif pH Transitions: A Study of the RAD17 Promoter Sequence. Biophys J 114:1804-1815
Rogers, R Aaron; Fleming, Aaron M; Burrows, Cynthia J (2018) Rapid Screen of Potential i-Motif Forming Sequences in DNA Repair Gene Promoters. ACS Omega 3:9630-9635
Wei, Xiaomu; Calvo-Vidal, M Nieves; Chen, Siwei et al. (2018) Germline Lysine-Specific Demethylase 1 (LSD1/KDM1A) Mutations Confer Susceptibility to Multiple Myeloma. Cancer Res 78:2747-2759
Sample, Danielle C; Samadder, N Jewel; Pappas, Lisa M et al. (2018) Variables affecting penetrance of gastric and duodenal phenotype in familial adenomatous polyposis patients. BMC Gastroenterol 18:115
Barrott, Jared J; Illum, Benjamin E; Jin, Huifeng et al. (2018) Paracrine osteoprotegerin and ?-catenin stabilization support synovial sarcomagenesis in periosteal cells. J Clin Invest 128:207-218

Showing the most recent 10 out of 1193 publications